
mEET US
PRISMA TEAM

In my path to becoming a physician-scientist, I have been deeply interested on the impact of genetic variation on brain disorders, and how to use discoveries in the field to enhance patient care. I have pursued clinical training in child, adolescent, and adult psychiatry, and research training in genetics and neuroscience, which has given me a unique perspective to blend insights from these diverse but complementary fields. Together with my collaborators, we identified the 17q12 deletion as a risk factor for autism and schizophrenia by pulling together genetic data from over 70,000 people worldwide, and we have expanded our work on this and other rare genetic variants within the context of the Simons Foundation and the Psychiatric Genetics Consortium. This work has propelled my drive to focus the next stage of my career in developing the scientific support and infrastructure required to bring research discoveries in genetics to clinical practice and continue forging the path towards precision medicine in psychiatry.

Daniel Moreno De Luca MD, MS
Director & Principal Investigator
In my path to becoming a physician-scientist, I have been deeply interested on the impact of genetic variation on brain disorders, and how to use discoveries in the field to enhance patient care. I have pursued clinical training in child, adolescent, and adult psychiatry, and research training in genetics and neuroscience, which has given me a unique perspective to blend insights from these diverse but complementary fields. My research has focused onthe genetic underpinnings of autism and other neuropsychiatric conditions, specifically on the role of rare genetic variants as risk factors for developmental brain disorders.

Molly Goldma MS, CGC
Genetics Counselor
I am a certified genetic counselor with experience in a variety of genetic counseling environments both clinical and research. I worked at Columbia New York Presbyterian Children's Hospital providing guidance and counseling to individuals and families for numerous genetic conditions in both prenatal and pediatric settings. I worked with early emerging data from chromosome microarrays to track the clinic's autism-related gene changes in attempt to elucidate a range of possible underlying causes. I received my master's degree from Mount Sinai School of Medicine in 2008.
Jack
Research Assitant

